+ regulatory T (Treg) cells are crucial for restraining inflammation in a variety of autoimmune diseases, including type 1 diabetes (T1D). However, the transcriptional and functional phenotypes of Treg cells within the pancreatic lesion remain poorly understood. Here we characterized pancreas-infiltrating Treg cells in the NOD mouse model of T1D and uncovered a substantial enrichment of the Treg subpopulation expressing the chemokine receptor CXCR3. Accumulation of CXCR3 + Treg cells within pancreatic islets was dependent on the transcription factor T-BET, and genetic ablation of T-BET increased the onset and penetrance of disease, abrogating the sex bias normally seen in the NOD model. Both male and female mice lacking T-BET + Treg cells showed a more aggressive insulitic infiltrate, reflected most prominently by elevated production of type 1 cytokines. Our results suggest the possibility of fine therapeutic targeting of Treg cells, in a tissue-and cell-subset-specific fashion, as a more focused immunotherapy for T1D.
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immunoregulation | immunogenomics | Treg subsets R egulatory T cells (Tregs) characterized by the transcription factor FoxP3 are critical for maintaining immunologic homeostasis, enforcing tolerance to self, and preventing runaway immune responses (1) . They regulate the activation and differentiation of conventional CD4 + T cells (Tconvs) and of many other cell lineages of the innate and adaptive immune systems through a variety of effector mechanisms (2) . There is increasing realization that Tregs have an extraimmunologic role in several tissues, controlling the noxious side effects of inflammation and promoting effective tissue repair. Examples of such "tissue-Tregs" include populations in the visceral adipose tissue (VAT) and in injured muscle (3) . Treg cells reside in secondary lymphoid organs [spleen and lymph nodes (LN)] but also radiate to barrier sites where they mediate harmonious coexistence with symbiont microbes (4) .
In line with these wide-ranging roles, Treg cells can adopt distinct subphenotypes that differ by their preferential expression of chemokine receptors, effector molecules, and cofactors that collaborate with FoxP3 to drive these functional nuances (5, 6) . These subphenotypes often are driven by transcription factors central to the differentiation and effector functions of the cells they regulate. For instance, BCL6 is induced in Tregs that regulate the interplay between Tconv and B cells in the germinal center (7) , and IRF4 and STAT3 are required for optimal control of Th2 and Th17 responses, respectively (8, 9) . One of the best characterized of these subphenotypes is the CXCR3 + Treg subset driven by the transcription factor T-BET (encoded by Tbx21), which has a particular role in controlling type 1 inflammation (10, 11) . Treg cells that cannot up-regulate T-BET fail to persist and control autoimmunity when transferred into FoxP3-deficient Scurfy mice (10), or to attenuate IFN-γ-driven pathology in mice infected with Toxoplasma gondii (11) . Similar Treg subsets expressing CXCR3 and T-BET have been described in humans (12) .
Type-1 diabetes (T1D) is an organ-specific autoimmune disease keyed to a breakdown in T lymphocyte tolerance to islet-cell antigens. After an occult phase of pancreatic infiltration that reduces the number and function of insulin-producing β-cells, transition to a metabolically overt phase of diabetes occurs when islets become sufficiently damaged and/or when local inflammation impairs β-cell function. The genetics of T1D in humans and the nonobese diabetic (NOD) mouse model point primarily to a dysfunction of CD4 + T cells, because class II genes of the MHC and several other loci that modify T-cell activation and regulation are linked to T1D susceptibility (13) . Although a constellation of immunocytes is present in the islet infiltrate, both CD4
+ and CD8 + T cells are dominant and are required for pathogenesis (13) . IFN-γ-producing Th1 CD4
+ T cells comprise the majority of effector T cells (13) , but evidence for an essential function of IFN-γ has been inconclusive: A knockout mutation in Tbx21 confers significant protection from T1D (14) , but deficits in Ifng, Ifngr1, or Ifngr2 have little or no effect (15) (16) (17) . Early evidence of a requirement for Ifngr1 in disease (18) was likely artifactual, resulting from a closely linked protective allele (16) .
Consistent with the importance of Treg cells in immunologic tolerance, there is much evidence that they control the progression of T1D in mice and humans. T1D is one of the autoimmune manifestations in FOXP3-deficient patients, occurring within the first months of life (13) . In NOD mice, Treg depletion by various means leads to accelerated diabetes, whereas augmentation of the Treg compartment by transfer or therapeutic manipulations mitigates disease progression (reviewed in ref. 19 ). Although Treg cells may limit the priming of islet-reactive Tconv cells in the pancreatic lymph nodes (PLNs) or their subsequent migration into the islets (20) (21) (22) , their primary role is to prevent the runaway destruction of the target organ by locally restraining inflammatory responses of both innate and adaptive immunocytes (21, (23) (24) (25) .
Here, to understand the mode of action of insulitic Tregs in T1D better, we have revisited earlier work (26) 
CXCR3
+ subset that appears to play a unique and nonredundant role in limiting the progression of T1D. (Fig. 1A and Table S1 ). (A few differential transcripts were typical of exocrine pancreatic cells and were discounted as residual contamination, despite double-sorting the cells.) Differential transcripts encoded molecules with known involvement in Treg inhibitory activity (e.g., Il10, Fgl2, and Lag3) or specific chemokine receptors (Cxcr3 and Ccr5) and several transcription factors that typically denote cell activation (Nr4a2, Fos, and Jun).
Results
Some of these mRNAs (e.g., Il10 and Lag3) were shared with other tissue-Tregs, but the direct comparison of various tissue-Treg populations in Fig. 1B showed that Tregs from the infiltrated pancreas were distinct from those found in the VAT, injured muscle, or colon. This segregation was confirmed by principal component analysis (Fig. 1C) . The cluster of transcripts more specifically represented in insulitic Tregs (Fig. 1B) was especially enriched for genes involved in cell growth and proliferation, suggesting rapid turnover, in line with previous reports (24, 26) . The diversity of tissue-Tregs is derived, in part, from the activity of transcription factors that are specific to the corresponding tissue, such as PPAR-γ in the VAT (27) (28) (29) (30) . These factors were not overexpressed in insulitic Tregs (Fig. 1D) , further underscoring the distinction of pancreatic Tregs from other tissue-Tregs.
To parse the pancreatic Treg transcriptome further for alterations in Treg-specific pathways, we overlaid various Treg signatures onto the comparison of pancreatic vs. splenic Treg gene-expression profiles. In agreement with the enrichment of cell-division transcripts, pancreatic Tregs demonstrated a significant up-regulation of a previously determined Treg activation signature (Fig. 1E , Left) (31). The transcription factors BLIMP-1 and IRF4 are required for Treg effector functions and their maintenance at tissue sites (8, 32) . Indeed, BLIMP-1-and IRF4-dependent Treg signatures were also biased in pancreatic Tregs (Fig. 1E , Center), possibly reflecting increased effector Treg differentiation in response to local inflammation. However, the strongest bias was observed when overlaying a signature specific to CXCR3 + Treg cells (Fig. 1E , Right and Fig. S1 ). This signature, which was derived by comparing splenic CXCR3
+ and CXCR3 − Tregs from C57BL/6 (B6) mice, included transcripts typical of the CXCR3 + Treg subset (Tbx21, Cxcr3) (10, 11) and others that have not been described (e.g., Lilrb4, Fgl2, Ccr5, and Gzmb). CXCR3 induction is dependent on T-BET in Tregs and other leukocyte subsets (10, 11, 33) , and both transcripts were overrepresented in insulitic Tregs (Fig. 1F ). However, we observed an intriguing disjunction + cells were strikingly enriched among Tregs in the pancreas as compared with those from the spleen (Fig. 2 A and B) , making up nearly half of insulitic Tregs. This enrichment was not observed in the PLNs, however, suggesting that CXCR3 + Tregs might be induced (or preferentially retained) in the autoimmune lesion.
The frequency of CXCR3 + Tregs in the pancreas remained relatively invariant over the course of insulitis, with comparable levels at 4 wk of age, when insulitis begins, and 14-20 wk of age, when islet infiltration is extensive and will soon lead to overt diabetes. (Fig. 2C) . In 7-to 18-wk-old NOD mice, CXCR3
+ Treg frequency did correlate negatively with the size of the inflammatory infiltrate (Fig. S2) , possibly denoting relevance in regulating disease. Unlike the pancreas, the frequency of CXCR3 + Tregs in the lymphoid organs increased slightly between 4 and 7 wk of age (Fig.  2C) . Total Treg frequency among pancreas-infiltrating CD4 + T cells diminished progressively with age (Fig. 2D) , in accordance with a previous report (24) . CXCR3 + Treg cells have been shown to be dependent on T-BET in B6 mice (10) . We generated conditional KO mice lacking T-BET specifically in Tregs on the NOD background (Foxp3
Cre

Tbx21
fl/fl with five or more backcrosses to NOD mice). CXCR3 + Tregs were almost fully ablated in these mice (Fig. 2E) , demonstrating their complete dependence on T-BET. In addition, Tregs have been reported to express IFN-γ in the circulation of T1D patients (34) and in the PLNs of NOD mice (35) . Although there was a slight elevation of Ifng transcripts in pancreas-infiltrating Tregs (Fig. 1A and Table S1 ), we detected little or no IFN-γ production from them (Fig. 2F) . Thus, T-BET-dependent, CXCR3 + Tregs constituted a large fraction of the pancreatic Treg compartment throughout the evolution of the disease and resembled bona fide Treg cells in their inability to produce inflammatory cytokines. fl/fl females (five-generation backcross) developed T1D at a higher incidence and with a markedly earlier onset than their control littermates (Fig. 3A) (diabetes is essentially never observed in our NOD colony before 10 wk of age). T1D penetrance in control littermates was lower than usual in NOD mice, likely because of the incomplete backcross, emphasizing the effect of deficiency. The difference in diabetes progression was even greater in males, which exhibited an incidence of overt disease unprecedented in our NOD colony, with proportions and timing of onset similar to those of their female siblings (Fig. 3B) . It was as if the pronounced sex bias in disease penetrance of T1D in NOD mice was abrogated by the absence of CXCR3 + Treg cells. Accordingly, insulitis was already profound in prediabetic Foxp3
Cre Tbx21
fl/fl mice of both sexes at 6 wk of age, when insulitis is usually incipient, as it was here in control littermates (Fig. 3 C and D) .
We then asked whether this profound effect of eliminating CXCR3 + Tregs would also be seen in a model of accelerated diabetes, BDC2.5/B6 g7 mice. These mice express in most of their CD4 + T cells the islet-reactive BDC2.5 TCR, introgressed from the NOD onto the B6.H2 g7/g7 genetic background, which provides disease-accelerating alleles (36) . Most, but not all, BDC2.5/B6 g7 mice developed early-onset diabetes between 4 and 6 wk of age, without sex bias. Disease penetrance in BDC2.5/B6 g7 .
Foxp3
fl/fl mice devoid of CXCR3 + Tregs was significantly increased (Fig. 3E) . Curiously, however, mice that did not develop early diabetes remained disease-free thereafter, as do standard BDC2.5/ B6 g7 mice (36) . Hence T-BET-dependent CXCR3 + Treg cells were indispensable for Treg-cell-mediated control of T1D in mice.
T-BET Promotes the Regulation of Type 1 Inflammation by Treg Cells
Without Affecting Their Accumulation in the Insulitic Lesion. In theory, deficiency in T-BET and the CXCR3 + Tregs that it controls might modulate T1D progression either by influencing CXCR3-dependent Treg traffic to and retention in the pancreas or by affecting Treg-suppressive function within the islets. (Fig. 4A) . The comparable frequencies of pancreatic Tregs in mice of the two genotypes could arise from enhanced proliferation and/or survival of Treg cells that lacked T-BET, thereby compensating for impaired CXCR3-mediated migration into the islets. However, proliferation of pancreatic Treg cells was equivalent in Foxp3   Cre   Tbx21 fl/fl mice and control littermates (Fig. 4B) .
Thus, disease exacerbation in mice lacking T-BET-dependent CXCR3 + Tregs likely resulted from defects in Treg function rather than from their recruitment to or homeostasis in the islets. Indeed, impaired Treg activity was apparent, in that many immunocyte populations in the pancreatic infiltrates of prediabetic Foxp3
Cre Tbx21 fl/fl mice had a more inflammatory tone [elevated frequencies and proliferation of CD4 + and CD8 + T cells; increased IFN-γ production by CD4 + , CD8 + , and γδ T cells and by innate lymphoid cells (ILCs); and heightened activation of antigen-presenting cells (APCs) (Fig. 4C) ] than seen in control littermates. Not all effector functions of immunocytes were equally affected, however, because the frequencies of Th17 cells and IFN-γ-producing NK cells remained constant; the latter observation is interesting in light of the documented first response of NK cells to Treg ablation (25, 37) . Thus, T-BET-dependent CXCR3 + Tregs played a crucial role in controlling autoimmune inflammation in the pancreas in a manner that could not be adequately compensated by numerically identical CXCR3 − Treg cells. Cre × Tbx21 fl/fl BDC2.5/B6 g7 mice of the indicated genotypes (males and females pooled) (log-rank test).
Discussion
Several lines of evidence have established the concept that FoxP3
tissue-Treg populations. Pancreatic Tregs were especially enriched for the T-BET-dependent, CXCR3 + subset. Importantly, these CXCR3 + Tregs seemed uniquely suited to restrain autoimmune attack of the pancreas, with a nonredundant role that could not be assumed by other Treg cells. These findings are pertinent to the pathogenesis pathways in T1D and have implications for therapeutic targeting of Tregs in human diabetes.
It is likely that IFN-γ, secreted locally by several types of immunocytes (T, NK, type 1 ILCs), is critical to the accrual of CXCR3 + Treg cells in the pancreas. This cytokine might induce the production of the CXCR3 ligands CXCL9/10 (38), thereby attracting CXCR3 + Tregs to or retaining them in the islets. Alternatively, IFN-γ might up-regulate T-BET and CXCR3 in Treg cells (10, 11) already present in the islets. This dual involvement of T-BET in both the aggressive Th1 cells and in their essential CXCR3 + Treg foil might help reconcile the confusing observations on the importance of IFN-γ, its receptor, and T-BET itself to disease progression in NOD mice (14, 15, 17, 18) .
A striking finding from this study was the abrogation of the sex bias in T1D incidence when T-BET + Treg cells were absent, with T1D occurring with quasi-superimposable incidences in males and females. Several explanations for the sex bias have been proposed, including hormonal effects and differences in the intestinal microbiota, but actual microbes have not been consistent between laboratories (39, 40) . Whatever the root, we might speculate that the relevant pathways involve CXCR3 + Treg cells, modifying their frequency or activity in a sex-biased manner. In this context, surveys at the Jackson Laboratory of the rates of diabetes incidence in different KO strains crossed onto the NOD background revealed that the normal sex bias disappeared in mice carrying mutations targeting the IL-12-IFN-γ signaling pathway (Ifng, Ifngr1, and Stat4) (40) . Increased secretion of IFN-γ in the PLNs of males relative to females has been reported and proposed to account for protection from T1D (40) , and one might extend this speculation by proposing that this overabundance of IFN-γ enhances CXCR3 + Treg function. However, we did not observe significant differences in CXCR3
+ Treg frequencies between males and females. What accounts for the nonreplaceable role of CXCR3 + Tregs in T1D? Tbx21 −/− Treg cells have suppressive activity equivalent to that of WT controls in in vitro suppression assays (14, 41) . In several in vivo contexts, such as the T-cell transfer model of colitis or the experimental autoimmune encephalomyelitis model of multiple sclerosis, CXCR3
+ Tregs appear functionally identical to bulk Treg cells and are dispensable for protection from disease (42, 43) . On the other hand, specific functional defects in controlling Th1 inflammation have been reported in the absence of CXCR3 + Tregs, including protection from autoinflammatory disease in Treg-deficient Scurfy mice and from allograft rejection (10, 41) . Our finding that mice lacking T-BET-dependent CXCR3 + Treg cells developed heightened insulitic inflammation without substantial changes in Treg frequency indicates that pancreatic autoimmunity is one of the contexts in which the activity of T-BET + Tregs is essential. T-BET likely modulates a specific facet of Treg activity relevant to the control of local Th1 responses and/or innate lymphocytes rather than promote a nonspecific activation of Treg cells, because the generation of Blimp-1 + effector Treg cells does not require T-BET (32). The transcripts differentially expressed in pancreatic vs. splenic Treg cells, which closely overlapped the CXCR3
− Treg differential (Fig. S1 ), likely include transcripts that are functionally relevant to the control of Th1 responses. No transcript is an immediately obvious candidate, although some (e.g., Fgl2 and Lag3) encode molecules previously described as being important in the control of Th1 responses (44, 45) . Another candidate is Il1r2 which specifies the decoy receptor for IL- Whether T-BET + CXCR3 + Tregs also have a central role in human T1D is conjectural at this point, but CXCR3 + Treg cells specific for Th1-inducing microbes have been identified in healthy humans (12) , and one might speculate that microbial influences on these cells could condition the propensity to progress from prediabetes to overt disease. Our results suggest that the therapeutic transfer of CXCR3 + Tregs might be more efficacious in treating T1D than the transfer of bulk Tregs expanded nonspecifically. Alternatively, one can imagine that targeting Treg-trophic factors via CXCR3 might be an effective means of enhancing this subset precisely for a targeted impact on T1D. 
Materials and Methods
Mice. NOD/ShiLtJ (NOD), NOD.Foxp3ires-gfp, NOD.Foxp3Cre, B6.Foxp3YFP-Cre, and BDC2.5/B6 g7 mice were maintained in the specific pathogen-free colony at Harvard Medical School (Institutional Animal Care and Use Committee-approved protocol 02954). Tbx21 fl/fl mice (50) were obtained from S. Reiner, Columbia University, New York, and were backcrossed to NOD mice for five or eight generations (genotyping for H-2 g7/g7 early in the backcross) before they were intercrossed.
Diabetes and Insulitis Assessments. NOD and BDC2.5/B6 g7 mice were monitored weekly for diabetes, from 8-30 or from 3-10 wk of age, respectively, as described (51) . Pancreata were processed and stained for flow cytometry as described (25) .
Gene-Expression Profiling and Analysis. Treg cells (30,000) were double-sorted into TRIzol (Invitrogen). Subsequent sample processing and hybridization onto Affymetrix MoGene 1.0 ST microarray chips were performed as described (52 
